Published in
American Association for the Advancement of Science, Science Translational Medicine, 496(11), 2019
DOI: 10.1126/scitranslmed.aav5989
Links
Tools
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
Journal article published in 2019 by
Christina Claus 
,
Claudia Ferrara,
Wei Xu,
Johannes Sam,
Sabine Lang,
Franziska Uhlenbrock,
Rosmarie Albrecht,
Sylvia Herter,
Ramona Schlenker,
Tamara Hüsser,
Sarah Diggelmann,
John Challier,
Ekkehard Mössner,
Ralf J. Hosse,
Thomas Hofer
and other authors.
,
Claudia Ferrara,
Wei Xu,
Johannes Sam,
Sabine Lang,
Franziska Uhlenbrock,
Rosmarie Albrecht,
Sylvia Herter,
Ramona Schlenker,
Tamara Hüsser,
Sarah Diggelmann,
John Challier,
Ekkehard Mössner,
Ralf J. Hosse,
Thomas Hofer
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Tumor-targeted 4-1BB agonists provide costimulation as combination partners for cancer immunotherapies in solid and hematological tumors.